摘要
目的:研究横纹肌肉瘤(RMS)中bcl-2、p53、PCNA表达与其临床病理的相关性。方法:对50例(随访41例)横纹肌肉瘤进行免疫组化ABC法标记。结果:bcl-2、p53基因蛋白和PCNA,发现bcl-2、p53、PCNA阳性表达率分别为28%、72%、70%,其阳性表达与年龄、性别及不同组织类型的RMS无关(P>0.05)。但与分化程度有关,p53、PCNA在低分化RMS阳性率分别为85%、95%,显著高于高分化RMS42.8%和14.3%(P<0.05),随访存活1年以内的p53、PCNA阳性率均为86.7%,亦明显高于存活超过3年以上的阳性率33.3%和41.7%(P<0.05)。而bcl-2在低分化RMS阳性20%显著低于高分化71.4%(P<0.05),随访存活1年以内的阳性率13.4%明显低于存活超过3年以上的41.4%(P<0.05)。p53与bcl-2阳性表达呈明显负相关,p53阳性率越高,而bcl-2阳性率越低。结论:PCNA、p53、bcl-2蛋白表达能比较准确地反映RMS的生物学特性,p53、bcl-2可作为肿瘤预后显著相关的有效指标。
Purpose In order to study the correlation between expression of oncogene protein products bcl 2, p53, PCNA and clinicopathological features in rhabdomyosarcoma(RMS). Methods 50 cases were stained by immunohistochemical ABC method.Results The positivity rates of bcl 2, p53 and PCNA were 28%, 72% and 70% respectively. These positive expression did not relate to age、sex and histological types, but related to differentiated degree. The positivity rates of p53, PCNA in the poor differentiated RMS was 85% and 95% respectively. While the positivity rate of those in the well differentiated was 42 8% and 14 3% respectively( P <0 05). In one year survivor both p53 and PCNA positivity rates were 86 7% and in more than 3 year survivors p53 and PCNA positivity rates were 33 3% and 41 7% respectively( P <0 05). The positivity rate of bcl 2 in the poor differentiated RMS was 20% while that in the well differentiated RMS was 71 4%( P <0 05). In one year survivor bcl 2 positivity rate was 13 4% and in more than 3 year survivals bcl 2 positivity rate 41 4%( P <0 05). A significant negative correlation was found between bcl 2 and p53 expression. Conclusions PCNA, p53 and bcl 2 may reflect proliferative activity more acurrately and objectively. The p53 and bcl 2 may be considered as prognostic indicators that strongly related to prognosis in RMS.p53 positivity may reflect a poor prognosis,but the bcl 2 positivity may reflect better prognosis.
出处
《临床与实验病理学杂志》
CAS
CSCD
1997年第2期116-118,I012,共3页
Chinese Journal of Clinical and Experimental Pathology